Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1227599-26-9 | MDL No. : | MFCD16606988 |
Formula : | C6H5BrClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | RPAYTSWGANTCGM-UHFFFAOYSA-N |
M.W : | 222.47 | Pubchem ID : | 71699976 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.07 |
TPSA : | 33.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.72 cm/s |
Log Po/w (iLOGP) : | 1.77 |
Log Po/w (XLOGP3) : | 1.32 |
Log Po/w (WLOGP) : | 1.84 |
Log Po/w (MLOGP) : | 1.25 |
Log Po/w (SILICOS-IT) : | 2.52 |
Consensus Log Po/w : | 1.74 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.43 |
Solubility : | 0.829 mg/ml ; 0.00372 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.62 |
Solubility : | 5.38 mg/ml ; 0.0242 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.33 |
Solubility : | 0.104 mg/ml ; 0.000468 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.71 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With triethylamine In dichloromethane at -15℃; for 2h; | AM.C Step C: MsCl (1.42 mL, 18.4 mmol) was added dropwise to a -15 °C solution of (3-bromo-5-chloropyridin-2-yl)methanol (3.72 g, 16.7 mmol) and triethylamine (4.66 mL, 33.4 mmol) in DCM (50 mL). The resulting mixture was allowed to stir at same temperature for 2 hours. The reaction mixture was quenched with water and diluted with EtOAc, and the aqueous layer was separated. The organic layer was washed with brine, dried over anhydrous Na2S04, filtered, and concentrated under reduced pressure to get crude. The crude was purified by silica gel column chromatography (15-20% EtO Ac/hexane) to get (3-bromo-5- chloropyridin-2-yl)methyl methanesulfonate (3.8 g, 76% yield) as a semisolid m/z (esi) M+l = 302.0. |
With triethylamine In dichloromethane at 0 - 20℃; Inert atmosphere; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | With methanol; sodium tetrahydroborate at 0 - 20℃; for 16.5h; | AM.B Step B: Sodium borohydride (4.37 g, 1 15.7 mmol) was added in small portions to a cooled (0 °C) solution of methyl 3-bromo-5-chloropicolinate (4.8 g, 19.3 mmol) in methanol (70 mL) over approximately 30 minutes. The reaction mixture was stirred at room temperature for 16 hours. The reaction mixture was then diluted with brine, and MeOH was evaporated under reduced pressure. The residue was extracted with EtOAc. The combined organic layers were dried over anhydrous Na2S0 , filtered, and evaporated to get (3-bromo-5- chloropyridin-2-yl)methanol (3.72 g, 88% yield) as a semisolid m/z (esi) M+1 = 224.0. |
[ 1189513-50-5 ]
3-Bromo-5-chloropicolinic acid
Similarity: 0.86
[ 760207-83-8 ]
3-Bromo-5-chloropicolinonitrile
Similarity: 0.78
[ 1646152-49-9 ]
2-(Bromomethyl)-5-chloropyridine hydrobromide
Similarity: 0.74
[ 1240594-87-9 ]
2-(3-Bromopyridin-2-yl)propan-2-ol
Similarity: 0.71
[ 1189513-50-5 ]
3-Bromo-5-chloropicolinic acid
Similarity: 0.86
[ 760207-83-8 ]
3-Bromo-5-chloropicolinonitrile
Similarity: 0.78
[ 209526-98-7 ]
(5-Chloropyridin-2-yl)methanol
Similarity: 0.77
[ 1646152-49-9 ]
2-(Bromomethyl)-5-chloropyridine hydrobromide
Similarity: 0.74
[ 137628-16-1 ]
3-Bromo-5-chloro-2-hydroxypyridine
Similarity: 0.70
[ 209526-98-7 ]
(5-Chloropyridin-2-yl)methanol
Similarity: 0.77
[ 1240594-87-9 ]
2-(3-Bromopyridin-2-yl)propan-2-ol
Similarity: 0.71
[ 137628-16-1 ]
3-Bromo-5-chloro-2-hydroxypyridine
Similarity: 0.70
[ 1227563-37-2 ]
(3-Bromo-5-(trifluoromethyl)pyridin-2-yl)methanol
Similarity: 0.69
[ 1189513-50-5 ]
3-Bromo-5-chloropicolinic acid
Similarity: 0.86
[ 760207-83-8 ]
3-Bromo-5-chloropicolinonitrile
Similarity: 0.78
[ 209526-98-7 ]
(5-Chloropyridin-2-yl)methanol
Similarity: 0.77
[ 1646152-49-9 ]
2-(Bromomethyl)-5-chloropyridine hydrobromide
Similarity: 0.74